The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
Objectives: This study was aimed at providing some insights into the real-life performance of the commercial, clinically validated anti-SARS-CoV-2 antibody assays. Methods: The residual, anonymized samples from 97 patients referred for anti-SARS-CoV-2 antibodies testing were included in the study. T...
Main Authors: | Jakub Swadźba, Maciej Bednarczyk, Tomasz Anyszek, Danuta Kozlowska, Andrzej Panek, Emilia Martin |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Practical Laboratory Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352551721000123 |
Similar Items
-
The real life performance of 7 automated anti-SARS-CoV-2 IgG and IgM/IgA immunoassays
by: Anyszek, T., et al.
Published: (2021) -
Results of anti-Toxoplasma gondii IgG, IgM, IgA and IgG Avidity testing in pregnant women in Rome, Italy
by: Carla Nisii, et al.
Published: (2012-12-01) -
Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2
by: Iulia Nedelcu, et al.
Published: (2021-06-01) -
Verifiering av EliA-metoden för analys av reumatoid faktor IgM och anti-CCP IgG
by: Kumbaric, Sana, et al.
Published: (2019) -
Comparison of chemiluminescent microparticle immunoassay (CMIA) with electrochemiluminescence immunoassay (ECLIA) for Carcinoembryonic antigen (CEA)
by: Nafija Serdarevic, et al.
Published: (2018-09-01)